首页> 外文OA文献 >Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
【2h】

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

机译:慢性淋巴细胞白血病患者亚群体细胞超突变的刻板模式:抗原选择在白血病发生中作用的意义

摘要

Somatic hypermutation (SHM) features in a series of 1967 immunoglobulin heavy chain gene (IGH) rearrangements obtained from patients with chronic lymphocytic leukemia (CLL) were examined and compared with IGH sequences from non-CLL B cells available in public databases. SHM analysis was performed for all 1290 CLL sequences in this cohort with less than 100% identity to germ line. At the cohort level, SHM patterns were typical of a canonical SHM process. However, important differences emerged from the analysis of certain subgroups of CLL sequences defined by: (1) IGHV gene usage, (2) presence of stereotyped heavy chain complementarity-determining region 3 (HCDR3) sequences, and (3) mutational load. Recurrent, "stereotyped" amino acid changes occurred across the entire IGHV region in CLL subsets carrying stereotyped HCDR3 sequences, especially those expressing the IGHV3-21 and IGHV4-34 genes. These mutations are un-derrepresented among non-CLL sequences and thus can be considered as CLL-biased. Furthermore, it was shown that even a low level of mutations may be functionally relevant, given that stereotyped amino acid changes can be found in subsets of minimally mutated cases. The precise targeting and distinctive features of somatic hypermutation (SHM) in selected subgroups of CLL patients provide further evidence for selection by specific antigenic element(s).
机译:检查了1967年从慢性淋巴细胞性白血病(CLL)患者获得的一系列免疫球蛋白重链基因(IGH)重排中的体细胞高突变(SHM)功能,并将其与公共数据库中非CLL B细胞的IGH序列进行了比较。在该队列中对所有1290个CLL序列进行了SHM分析,与种系的同源性小于100%。在同类研究中,SHM模式是规范SHM过程的典型特征。但是,通过分析以下定义的CLL序列的某些亚组,出现了重要差异:(1)IGHV基因的使用,(2)存在刻板印象的重链互补决定区3(HCDR3)序列和(3)突变负荷。在携带定型HCDR3序列(特别是表达IGHV3-21和IGHV4-34基因的那些)的CLL亚组中,整个IGHV区域中发生了重复的“定型”氨基酸变化。这些突变在非CLL序列中不很常见,因此可以认为是CLL偏倚的。此外,研究表明,即使在微量突变病例的子集中也可以找到定型的氨基酸变化,即使是低水平的突变也可能与功能相关。在CLL患者的选定亚组中,体细胞超突变(SHM)的精确靶向和独特特征为通过特定抗原成分进行选择提供了进一步的证据。

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号